PhenX - human papillomavirus vaccine use protocol 100802

General Details:

Name:
PhenX - human papillomavirus vaccine use protocol 100802
Steward:
LOINC
Definition:
The interviewer asks the individual whether s/he ever received a human papillomavirus (HPV) vaccination. If the response is yes, the interviewer asks about number of shots received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no," then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL® is also known internationally as Silgard. European Medicines Agency. (2009, September 25). Silgard European Public Assessment Report. Waknine, Y. (2006, October 2). International approvals: Singulair and Gardasil/Silgard. Medscape Today. Note: GARDASIL® by Merck & Co. is approved by the U.S. Food and Drug Administration (FDA) for use in females ages 9-26 and males ages 9-26. Note: CERVARIX® is manufactured by GlaxoSmithKline Biologicals and approved by the FDA for use in females ages 10-25.
Registration Status:
Qualified

Designations:

Designation:
PhenX - human papillomavirus vaccine use protocol 100802
Tags:
Long Common Name
Designation:
PhenX - HPV vaccine use protocol
Tags:
Short Name

Designations:

Definition:
The interviewer asks the individual whether s/he ever received a human papillomavirus (HPV) vaccination. If the response is yes, the interviewer asks about number of shots received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no," then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL® is also known internationally as Silgard. European Medicines Agency. (2009, September 25). Silgard European Public Assessment Report. Waknine, Y. (2006, October 2). International approvals: Singulair and Gardasil/Silgard. Medscape Today. Note: GARDASIL® by Merck & Co. is approved by the U.S. Food and Drug Administration (FDA) for use in females ages 9-26 and males ages 9-26. Note: CERVARIX® is manufactured by GlaxoSmithKline Biologicals and approved by the FDA for use in females ages 10-25.
Tags:
Source: Regenstrief LOINC

Properties:

Key:
Related Names
Value:
PanPanelPANEL.PHENX
PanlPhenX - HPV vaccine use protocolPnl
Point in timeRandom
Key:
Related Codes
Value:
Code SystemCodeCode TextCode Version
https://www.phenxtoolkit.org100802human_papillomavirus_vaccine_use
Key:
Fully-Specified Name
Value:
ComponentPropertyTimeSystemScaleMethod
PhenX - human papillomavirus vaccine use protocol 100802-Pt^Patient-PhenX
Key:
Basic Attributes
Value:
ClassTypeFirst ReleasedLast UpdatedOrder vs- ObservationPanel Type
PANEL.PHENXClinicalVersion 2.68Version 2.68OrderPanel

Identifiers:

Source:
NLM
Id:
gTwHQHRsE_
Version:
1.0
Source:
LOINC
Id:
94327-4
Version:
2.69